Introduction
The pathology of patent lungworm (Dictyocaulus spp.) infection in ruminants is characterised by chronic catarrhal bronchitis and bronchiolitis, bronchial epithelial and mucous cell hyperplasia, increased peribronchiolar fibrous tissue and smooth muscle, and prominent eosinophil and mast cell infiltrates [1] [D.Collie pers. observation]. Understanding the factors that control the tissue remodelling processes that underlie the pathology would be of some relevance to human diseases such as asthma where pronounced airway wall remodelling occurs [2] .
Mast cells are likely to play a fundamental role during tissue remodelling processes. In addition to the expression of matrix components (type VIII collagen alpha-1 chain) [3] , mast cells contain an abundance of mediators (VEGF, FGF-2, PDGF, TGF-beta, NGF, IL-4, IL-8) that are at least potentially directly linked to neoangiogenesis, fibrinogenesis or re-epithelization processes.
Central among such mediators is transforming growth factor-β1 (TGF-β1). This growth factor promotes ECM deposition by stimulating different collagen, elastin, fibronectin and proteoglycan genes to produce these ECM components [4] [5] [6] . TGF-β1 down-regulates proteinase genes and up-regulates proteinase inhibitor genes [7, 8] and is also a potent immunosuppressive agent [9] and a potent chemoattractant under certain circumstances [10] .
In addition, mast cells, through the release of TNF-α and other cytokines, can importantly influence the recruitment and/or function of additional effector cells such as eosinophils, neutrophils and lymphocytes [11] .
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Mast cells are a phenotypically heterogeneous population with respect to tissue site, fixation properties, histochemical staining, biochemistry and functional activity. This heterogeneity is particularly reflected in the expression of mast cell granule proteases. In man, mast cells comprise a population that contains tryptase and chymase (MCTC) and one that contains only tryptase (MCT). The MCTC is found predominantly in skin and at subepithelial locations in the bronchial, nasal, and gastrointestinal mucosa, whereas the MCT is located predominantly in alveolar walls, gastrointestinal epithelium, and in the airway epithelium of patients with allergic disease.
Similarly, sheep demonstrate mast cell heterogeneity. Using a polyclonal antihuman tryptase antibody and a monoclonal antibody against sheep mast cell protease-I (SMCP-I), a chymase originally isolated from gastric mast cells, it is possible to demonstrate variation in immunoreactivity depending on the specific anatomical location. For example, SMCP-I is expressed in mast cells in the mucosa of the gut but not in the submucosa or adjacent muscularis [12] .
Interestingly, in the lung, available evidence points to minimal SMCP and maximal tryptase immunoreactivity in mast cell populations surrounding the airways in normal sheep [12] .
Dynamic flux in the relative proportions of phenotypically distinct mast cell populations may have important bearing on lung allergic responses. Indeed, in in murine rodents, the β-chymases, mouse mast cell protease-1 (mMCP-1) and rat mast cell protease -II (rMCP-II), which characterise mucosal mast cells in these species, are secreted systemically and into the gut lumen during 6 gastrointestinal allergic responses [13, 14] . Further, transforming growth factor beta-1 (TGF-β1) has recently been implicated as a potential influence on such expression in the mucosal environment [15] .
In an effort to elucidate the mechanisms underlying mast cell mediated events in ovine allergic pulmonary disease we have developed a novel model based on systemic sensitisation with a recombinant antigen, DvA-1, from the bovine lungworm D. viviparus. DvA-1 is a retinoid-binding polyprotein and has similar sequence and deduced structural similarities to the ABA-1 allergen found in the respective human and porcine gastro-intestinal nematodes Ascaris lumbricoides and Ascaris suum [16, 17] . We report here on the inflammatory and immune events that occur following local lung challenge with the same antigen.
Materials and Methods
Animals: Sixteen crossbred sheep (Shetland x and Merino x; 8 F and 8 MN) (bodyweight: 26 -49 kg) were used in this study. Animals were treated with anthelminthic prior to entry into the study and were adjudged to be free from significant pulmonary disease on the basis of clinical examination.
Production of recombinant DvA-1 polypeptide: Production of recombinant polypeptide was essentially as previously described [17] . Briefly, DNA encoding were coated with 50µl of rDvA-1 antigen (2 µg/ml in 50mM NaHCO 3 (pH 9.6)) and incubated overnight at 4°C. After washing twice with PBS/0.05% tween20, blocking buffer (2% goat serum in PBS/0.05% tween20) was added to each well Experimental design: Two weeks after the last intramuscular injection of DvA-1:ALUM four spatially disparate lung segments were selected on bronchoscopic examination and their position carefully mapped. The segments were randomly assigned to one of two challenge protocols, namely repeated (3x) weekly aerosol challenge with DvA-1 (3xDVA) or repeated (3x) weekly aerosol challenge with saline (3xSAL) (Figure 1 ). Two weeks after the third challenge, BALF was collected from one segment randomly selected from the pair subjected to each of the challenge protocols. Two months after the third challenge, one of the two segments previously repeatedly challenged with DvA-1 was challenged again with DvA-1 whilst the other was challenged with saline.
Similarly, one of the two segments previously repeatedly challenged with saline was challenged again with saline whilst the other was challenged with DvA-1.
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Twenty-four hours after the last challenge, sheep were re-anaesthetised and BALF collected from each of the four treated segments (3xSAL:SAL; 3xSAL:DVA; 3xDVA:SAL; 3xDVA:DVA). Three sheep were killed 24 hr after the last challenge to provide tissue for histopathological and immunohistochemical analysis.
Data analysis: Within sheep, between segment comparisons were assessed using Freidman non-parametric tests for related variables. Where significant changes were identified, further analysis was conducted using Wilcoxon signed rank tests to compare between specific segments. Degrees of association between measurements were assessed using the Spearman rank correlation coefficient (r s ).
Results
BALF cytology: Two weeks after the third segmental challenge, BALF cellular parameters did not differ between 3xSAL and 3xDVA segments (data not shown). Twenty four hours after the final segmental challenge, Freidman tests revealed significant differences between segments with respect to total cell counts, comprising changes in the absolute numbers of neutrophils and eosinophils (table 1) . BALF from 3xSAL:DVA and 3xDVA:DVA segments contained significantly more cells than 3xSAL:SAL segments (p<0.05) with neutrophils the predominant cell type involved (p<0.01)(figure 2a). A significant increase in the number of eosinophils in 3xSAL:DVA, 3xDVA:SAL and 3xDVA:DVA segments (p<0.01, p<0.05 and p<0.01 respectively) was noted (figure 2b).
TGF-β1 levels in BALF: There were no significant differences between segments with respect to levels of total TGF-β1 in BALF twenty four hours after the final segmental challenge. However, there were significantly increased levels of active TGF-β1 in the 3xDVA:SAL segments (p<0.05) and a trend towards increased levels in the 3xDVA:DVA segments (p=0.08) relative to levels in the 3xSAL:SAL segments. Levels of total and active TGF-β1 are depicted in Figure 3 . Total TGF-β1 levels were significantly correlated with absolute numbers of eosinophils in 3xSAL:SAL, 3xSAL:DVA and 3xDVA:DVA 
Discussion
Lung nematode infection is characterised by prominent mastocytosis.
Crosslinking of pre-bound specific anti-parasite IgE antibody on the surface of these cells is believed to result in degranulation with the release of a variety of mediators which have the collective effect of increasing vascular permeability, causing local vasodilation, bronchial and visceral smooth muscle contraction and local inflammation. Although such effects will contribute towards nematode expulsion, chronic mast cell-mediated inflammation may contribute significantly towards the extensive tissue remodelling that is a feature of lungworm infection in ruminants [1, 22] . We sought to develop a model system appropriate to the investigation of the role of mast cells in this regard.
Several factors contributed towards our adoption of a segmental, rather than whole lung, approach to challenge. Wherein responses can be considered local such an approach allows each animal to serve as its own control, thus reducing the extent of inter-animal variability associated with whole lung studies.
Responses are limited to defined areas of the lung and as such are associated with no discernible clinical effect. Segmental approaches have hitherto proved valuable in the context of defining, at functional, cellular and immune levels, the local lung response to antigen challenge in both experimental animals and in man [23] [24] [25] [26] [27] [28] [29] [30] .
Sensitisation with DvA-1 in ALUM resulted in a vigorous systemic antibody response characterised by increased antigen-specific IgG.
Cellular response to antigen challenge was characterised by a neutrophil inflammatory cell infiltrate at 24hr. Although this is consistent with data in dogs in response to particulate [31] and soluble [32] antigen, and in healthy human subjects [33] and subjects with hypersensitivity pneumonitis [34] in response to antigen, some comment is appropriate in relation to the possible influence of endotoxin in contributing to this response. Indeed it has been demonstrated that endotoxin, either sourced to the antigen preparation [35] or arising as a specific consequence of the bronchoscopy procedure [36] , may contribute to BALinduced lung inflammation. A total of 0.8 EU was delivered to each segment during the challenge procedures, an amount considerably less than the 12.5 EU/ml suggested as being more likely to alter the cellular inflammatory response of human subjects to allergen [35] . Although it is acknowledged that species vary considerably in their response to endotoxin [37] , in defence of this particular inter-species comparison, it is of note that sheep do appear to share a similar endotoxin sensitivity to man [38] . Thus it is considered unlikely that endotoxin contamination of the antigen preparation made a significant contribution to the observed neutrophilic influx. Further, the adopted segmental approach controls for the possibility of a lung neutrophilic response arising as a consequence of the bronchoscopic procedure itself.
All segments with an immediate or long-term history of exposure to DvA-1 had increased numbers of eosinophils in BALF 24hr after challenge. Although the effect was most striking in segments with concomitant neutrophilic inflammation,
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numbers were in addition increased in the 3xDvA:SAL segment relative to the 3xSAL:SAL segment. The median absolute eosinophil count from 3xSAL:SAL segments was 166 cells/ml whereas the median count from 3xDVA:DVA segments was 1.7 x 10 3 cells/ml, representing 0.2 and 0.8% of the total cell count respectively. By way of comparison, in Ascaris suum allergic sheep the whole lung response to inhaled allergen is characterised by less than 0.5% of total cells being identified as eosinophils at the 24hr time point after challenge [39] . Overall, such cell counts are modest both in relation to the eosinophilic response seen during natural lungworm infection [22, 40] , and in comparison with changes seen in allergic human subjects in response to segmental antigen challenge. In the latter regard, in ragweed-allergic asthmatics, absolute eosinophil counts increased from a mean of 0.49x10 4 /ml BALF (3.7% of total) to 59.0 x 10 4 /ml (~56%) at 24hr after challenge with antigen [22] .
We examined cellular and immune changes at 24h after challenge. In an analogous canine model, the numbers of eosinophils in BALF were significantly raised 4 days after challenge with the relevant antigen [41, 42] . Although preliminary data suggests similar eosinophil kinetics in the present model (D.
Collie, unpublished observation), further time-course evaluation after antigen challenge will be necessary to fully define such events post-challenge.
The present study demonstrates that antigen specific IgG is present in BALF of segments with a prior history of exposure to a recombinant antigen derived from D.viviparus. Indeed the disassociation of antibody levels in BALF from concomitant inflammation (comparing 3xDVA:DVA and 3xDVA:SAL segments)
suggests that antibody is locally derived rather than a reflection of a serum response. These findings are consistent with extensive studies in dogs [43] [44] [45] [46] [47] [48] .
Our findings demonstrate a significant increase in the ratio of SMCP-1 and tryptase expressing cells, to toluidine blue stained cells in airways from 3xDvA:DvA segments relative to 3xSAL:SAL segments. It is of some interest that the tryptase:toluidine blue ratio was close to 1.0 in all bar the 3xDvA:DvA segment whereas the SMCP:toluidine blue ratio was much lower (~0.25) in these segments. Further immunohistochemical analysis using dual staining is required to ascertain firstly whether these separate proteases are contained within the same population of cells and secondly, whether, as is the case in human bronchi [49] , differences exist in relation to protease expression and anatomic sublocation in the airway wall.
Regardless of the specific roles that these proteases play in our model system, clearly there would appear to be a requirement for both inflammatory and local lung immune components in dictating the conditions necessary for their expression. The twin observations that the pleiotropic cytokine, transforming growth factor beta 1 (TGF-β1), has been shown to play an important role in vitro in promoting the expression of mMCP-1 in cultured mBMMC [15] and is raised 24 hr following segmental bronchoprovocation of atopic asthmatics with allergen [33] , prompted our measurement of this cytokine in this study.
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We were able to demonstrate an increase in the levels of active TGF-β1 in BALF 24h after challenge in 3xDVA:SAL segments and a trend towards an increase in 3xDVA:DVA segments. The implication would be that lung segments chronically challenged with DvA-1 and which are uniquely characterised by eosinophilia and increased levels of local antibody production have in place mechanisms which are responsible for activating TGF-β1.
Principal mechanisms include the cleavage [50] or conformational alteration of latency associated peptide (LAP) [51, 52] , which noncovalently associates with TGF-β and prevents receptor binding. It remains to be established whether Eosinophils appear to be a primary source of TGF β1 mRNA [53, 54] in asthma, a finding that adds credence to our observed association between the number of eosinophils and the levels of total TGF-β1 in BALF in all bar the 3xDVA:SAL segment. This latter segment was characterised by a significant increase in active TGF-β1 and such activation of total TGF-β1 may have contributed to the observed lack of association with eosinophil numbers in this segment.
In conclusion, we have demonstrated that repeated local lung challenge of 
